Therapeutic potential of non-peptide chymase inhibitors

By Doggrell Sheila A  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 5, 2008-05 ,pp. : 485-499

Informa Healthcare

Access to resources Recommend Favorite

Structure-based design in drug discovery - the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

By Pritchard M.C.   Raphy J.   Singh L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide G-protein activators as promising tools in cell biology and potential drug leads

By Nurnberg B.   Togel W.   Krause G.   Storm R.   Breitweg-Lehmann E.   Schunack W.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 1, 1999-01 ,pp. : 5-30

Elsevier

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Paranjape S.B.   Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 825-834

Informa Healthcare

Access to resources Recommend Favorite